Figure 4.
Representation of Bempegaldesleukin and its biased IL2Rβγ receptor binding for enhanced IL-2-mediated immunotherapy of cancer. Reproduced under the terms of the CC BY 4.0 license. [173] Copyright 2017, Charych et. al.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.